Antidiabetic drugs and neuroendocrine neoplasms: a double-edged sword?
Minerva Med
.
2021 Dec;112(6):683-685.
doi: 10.23736/S0026-4806.21.07846-0.
Author
Alessandra Dicitore
1
Affiliation
1
Department of Medical Biotechnology and Translational Medicine (BIOMETRA), University of Milan, Milan, Italy - alessandra.dicitore@libero.it.
PMID:
35168303
DOI:
10.23736/S0026-4806.21.07846-0
No abstract available
Publication types
Editorial
MeSH terms
Diabetes Mellitus, Type 2 / drug therapy*
Humans
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use*
Neuroendocrine Tumors* / chemically induced
Substances
Hypoglycemic Agents